Valeant Pharmaceuticals International Stock Filter Stocks by Fundamentals
Valeant Pharmaceuticals International fundamentals help investors to digest information that contributes to Valeant Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Valeant Stock. The fundamental analysis module provides a way to measure Valeant Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Valeant Pharmaceuticals stock.
Valeant |
Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
| All Next | Launch Module |
Valeant Fundamentals
| Return On Equity | -21.51 | |||
| Return On Asset | 0.69 | |||
| Profit Margin | (10.65) % | |||
| Operating Margin | 5.01 % | |||
| Current Valuation | 32.38 B | |||
| Shares Outstanding | 349.3 M | |||
| Shares Owned By Insiders | 0.30 % | |||
| Shares Owned By Institutions | 51.10 % | |||
| Number Of Shares Shorted | 14.62 M | |||
| Price To Earning | 3.43 X | |||
| Price To Book | 1.40 X | |||
| Price To Sales | 0.95 X | |||
| Revenue | 8.61 B | |||
| Gross Profit | 6.18 B | |||
| EBITDA | 3.4 B | |||
| Net Income | (917 M) | |||
| Cash And Equivalents | 909 M | |||
| Cash Per Share | 2.60 X | |||
| Total Debt | 25.27 B | |||
| Debt To Equity | 558.60 % | |||
| Current Ratio | 1.18 X | |||
| Book Value Per Share | 16.77 X | |||
| Cash Flow From Operations | 1.77 B | |||
| Short Ratio | 1.80 X | |||
| Earnings Per Share | 6.83 X | |||
| Price To Earnings To Growth | 3.05 X | |||
| Number Of Employees | 20.7 K | |||
| Beta | -0.93 | |||
| Market Capitalization | 8.17 B | |||
| Total Asset | 2.24 B | |||
| Retained Earnings | (2.75 B) | |||
| Working Capital | (23.53 M) | |||
| Current Asset | 321.63 M | |||
| Current Liabilities | 345.16 M | |||
| Z Score | 4.9 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Valeant Stock
If you are still planning to invest in Valeant Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Valeant Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |